# Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

> **NCT00844480** · PHASE2 · TERMINATED · sponsor: **Thomas J. Schnitzer** · enrollment: 17 (actual)

## Conditions studied

- Bone Loss

## Interventions

- **DRUG:** zoledronic acid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00844480
- **Lead sponsor:** Thomas J. Schnitzer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** difficulty in enrollment
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00844480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00844480, "Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00844480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*